Literature DB >> 12882527

Clinical applications of proteomics: proteomic pattern diagnostics.

Emanuel E Petricoin1, Cloud P Paweletz, Lance A Liotta.   

Abstract

Clinical proteomics is an exciting new subdiscipline of proteomics that involves bedside application of proteomic technologies. A new and potentially revolutionary technology and approach for early disease detection, surveillance, and monitoring is proteomic pattern diagnostics. Using this approach, high throughput mass spectrometry generates a proteomic fingerprint of a given body fluid, such as serum or nipple fluid aspirants (NAF), in less than 30 s. This information archive is then used by new types of bioinformatic pattern recognition algorithms to identify patterns of protein changes that can discriminate cancer from healthy and unaffected individuals. This entire process can take place in less than a minute and requires only a droplet of blood, NAF, or ductal lavage washings. The new concept that is introduced by this platform is that the underlying identities of the proteins that comprise the patterns are not known and do not need to be known; the pattern itself becomes the diagnostic.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12882527     DOI: 10.1023/a:1024042200521

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  34 in total

1.  The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification.

Authors:  Haleem J Issaq; Timothy D Veenstra; Thomas P Conrads; Donna Felschow
Journal:  Biochem Biophys Res Commun       Date:  2002-04-05       Impact factor: 3.575

Review 2.  Clinical proteomics: translating benchside promise into bedside reality.

Authors:  Emanuel F Petricoin; Kathryn C Zoon; Elise C Kohn; J Carl Barrett; Lance A Liotta
Journal:  Nat Rev Drug Discov       Date:  2002-09       Impact factor: 84.694

Review 3.  Breast cancer (1)

Authors:  J R Harris; M E Lippman; U Veronesi; W Willett
Journal:  N Engl J Med       Date:  1992-07-30       Impact factor: 91.245

4.  Breast-cancer diagnosis with nipple fluid bFGF.

Authors:  Y Liu; J L Wang; H Chang; S H Barsky; M Nguyen
Journal:  Lancet       Date:  2000-08-12       Impact factor: 79.321

5.  Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease.

Authors:  Z Xiao; B L Adam; L H Cazares; M A Clements; J W Davis; P F Schellhammer; E A Dalmasso; G L Wright
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

6.  Use of proteomic patterns in serum to identify ovarian cancer.

Authors:  Emanuel F Petricoin; Ali M Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn; Lance A Liotta
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

7.  Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2.

Authors:  S K Sharan; M Morimatsu; U Albrecht; D S Lim; E Regel; C Dinh; A Sands; G Eichele; P Hasty; A Bradley
Journal:  Nature       Date:  1997-04-24       Impact factor: 49.962

8.  Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer.

Authors:  Darrick Carter; John F Douglass; Charisa D Cornellison; Marc W Retter; Jeffrey C Johnson; Angela A Bennington; Timothy P Fleming; Steven G Reed; Raymond L Houghton; Deborah L Diamond; Thomas S Vedvick
Journal:  Biochemistry       Date:  2002-05-28       Impact factor: 3.162

9.  Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.

Authors:  Jinong Li; Zhen Zhang; Jason Rosenzweig; Young Y Wang; Daniel W Chan
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

10.  Nipple aspirate cytology for the study of breast cancer precursors.

Authors:  E B King; K L Chew; N L Petrakis; V L Ernster
Journal:  J Natl Cancer Inst       Date:  1983-12       Impact factor: 13.506

View more
  17 in total

1.  Analysis of low-abundance, low-molecular-weight serum proteins using mass spectrometry.

Authors:  Karen Merrell; Katie Southwick; Steven W Graves; M Sean Esplin; Nathan E Lewis; Craig D Thulin
Journal:  J Biomol Tech       Date:  2004-12

2.  Phyloproteomics: what phylogenetic analysis reveals about serum proteomics.

Authors:  Mones Abu-Asab; Mohamed Chaouchi; Hakima Amri
Journal:  J Proteome Res       Date:  2006-09       Impact factor: 4.466

3.  Systematic internal standard selection for capillary liquid chromatography-mass spectrometry time normalization to facilitate serum proteomics.

Authors:  Karen Merrell; Craig D Thulin; M Sean Esplin; Steven W Graves
Journal:  J Biomol Tech       Date:  2008-12

4.  Protein identification and quantification by two-dimensional infrared spectroscopy: implications for an all-optical proteomic platform.

Authors:  Frédéric Fournier; Elizabeth M Gardner; Darek A Kedra; Paul M Donaldson; Rui Guo; Sarah A Butcher; Ian R Gould; Keith R Willison; David R Klug
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-01       Impact factor: 11.205

5.  Selective enrichment and sensitive detection of peptide and protein biomarkers in human serum using polymeric reverse micelles and MALDI-MS.

Authors:  Nadnudda Rodthongkum; Rajasekhar Ramireddy; S Thayumanavan; W Vachet Richard
Journal:  Analyst       Date:  2011-12-23       Impact factor: 4.616

Review 6.  The role of proteomics in the diagnosis of chorioamnionitis and early-onset neonatal sepsis.

Authors:  Irina A Buhimschi; Catalin S Buhimschi
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 7.  Proteomics in cancer screening and management in gynecologic cancer.

Authors:  Wei Hu; Weiguo Wu; Ryuji Kobayashi; John J Kavanagh
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

Review 8.  Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears.

Authors:  M E de Noo; R A E M Tollenaar; A M Deelder; L H Bouwman
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

9.  Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers.

Authors:  Cynthia Kuk; Vathany Kulasingam; C Geeth Gunawardana; Chris R Smith; Ihor Batruch; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2008-12-01       Impact factor: 5.911

Review 10.  The role of ductal lavage in the management of women at high risk for breast carcinoma.

Authors:  Seema A Khan
Journal:  Curr Treat Options Oncol       Date:  2004-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.